Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 7, 2007 - Issue 6
Submit an article Journal homepage
36
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

A systematic review of the cost–effectiveness of peginterferon alfa-2b in the treatment of chronic hepatitis C

Jonathan Shepherd Southampton Health Technology Assessments Centre (SHTAC), Wessex Institute, Mailpoint 728, Boldrewood, University of Southampton, Southampton, SO16 7PX, UK. [email protected]
&
Jeremy Jones Southampton Health Technology Assessments Centre (SHTAC), Wessex Institute, Mailpoint 728, Boldrewood, University of Southampton, Southampton, SO16 7PX, UK. [email protected]
Pages 577-595 | Published online: 09 Jan 2014

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ramón San Miguel, Vicente Gimeno-Ballester & Javier Mar. (2014) Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literature. Expert Review of Pharmacoeconomics & Outcomes Research 14:3, pages 387-402.
Read now

Articles from other publishers (2)

Huyen Anh Nguyen, Graham S. Cooke, Jeremy N. Day, Barnaby Flower, Le Thanh Phuong, Trinh Manh Hung, Nguyen Thanh Dung, Dao Bach Khoa, Le Manh Hung, Evelyne Kestelyn, Guy E. Thwaites, Nguyen Van Vinh Chau & Hugo C. Turner. (2020) The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam. Wellcome Open Research 4, pages 129.
Crossref
Huyen Anh Nguyen, Graham S. Cooke, Jeremy N. Day, Barnaby Flower, Le Thanh Phuong, Trinh Manh Hung, Nguyen Thanh Dung, Dao Bach Khoa, Le Manh Hung, Evelyne Kestelyn, Guy E. Thwaites, Nguyen Van Vinh Chau & Hugo C. Turner. (2019) The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam. Wellcome Open Research 4, pages 129.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.